The Effect of Astragalin on Airway Inflammation in Asthmatic Mice

MA Xiaofei,MA Liguang,LIU Hanye,WANG Dandan,SONG Xinyi,SONG Yilan,YAN Guanghai,LI Liangchang,SUN Lianping
DOI: https://doi.org/10.13431/j.cnki.immunol.j.20220132
2022-01-01
Abstract:This study is aimed to investigate the effect of astragalin(AG) on airway inflammation in an ovalbumin(OVA)-induced mouse asthma model.After the model was established,the number of inflammatory cells was counted by Diff-Quik staining;the levels of IL-4,IL-5,IL-13,total IgE and OVA-specific IgE in BALF were measured by ELISA.HE staining was used to observe the inflammatory changes in mouse lung tissue.Reactive oxygen species(ROS) levels were measured by DCFH-DA fluorescent probe,and superoxide dismutase(SOD) and malondialdehyde(MDA) contents in lung tissue were measured by corresponding kits.Western blot was used to detect the expression of IL-4,IL-5,IL-13,NOX2,p47 phox,TXNIP,NLRP3,cleaved Caspase-1,and IL-1β in lung tissues.Data showed that AG reduced the number of inflammatory cells in BALF,decreased IL-4,IL-5,IL-13 levels in BALF and lung tissue,and reduced total IgE and OVA-specific IgE levels in BALF.AG also reduced inflammatory cell infiltration in the lungs of asthmatic mice.Furthermore,AG inhibited NOX2 and p47 phox expression,decreased ROS levels and MDA content,and increased SOD activity,thereby inhibiting TXNIP and NLRP3 inflammatory body activation.In conclusion,AG may reduce airway inflammation in asthma by regulating oxidative stress response and affecting NLRP3 inflammasome activation,and the mechanism may be related to the inhibition of NOX2/ROS/TXNIP/NLRP3 signaling pathway.
What problem does this paper attempt to address?